This article is part of the series Everyday MOL-BIO which explains the science behind familiar medications, cosmetics, and everything else
Viral mediated expression of insulin-like growth factor I blocks the aging-related loss of skeletal muscle function
The Denmark-based company announced Wednesday it had received a Complete Response Letter for dasiglucagon, which it was proposing for the ultra-rare genetic disease congenital hyperinsulinism, due to the timing of a third-party manufacturing facility reinspection. In an initial visit, the FDA had flagged deficiencies in a third-party contract manufacturer, which the company claims had been resolved by the time of a reinspection in August/September 2024
This means your tissues don't get enough oxygen-rich blood, leading to symptoms like fatigue and paleness
Testosterone, where indicated, supports lean mass preservation and physical resilience, particularly relevant during the weight loss that GLP-1 therapy produces
Richardson AJ, McKain N, Wallace RJ